Navigation Links
Lycera Closes $36 Million Series A Financing
Date:4/16/2009

ANN ARBOR, Mich., April 16 /PRNewswire/ -- Lycera Corp. today announced it has closed a $36 million Series A financing.

The company, which is developing novel small-molecule pharmaceuticals to treat autoimmune diseases such as rheumatoid arthritis and inflammatory bowel disease, has received $10 million as a first tranche of the financing and will receive the remainder of the proceeds in two tranches as specific milestones are met. InterWest Partners, ARCH Venture Partners and Clarus Ventures co-led the financing. EDF Ventures, which led a seed financing in November 2006, is also participating.

In conjunction with the closing, Jeffrey Leiden, M.D., Ph.D., a managing director with Clarus; Kristina Burow, a partner with ARCH; and Nina Kjellson, a general partner with InterWest, have joined Lycera's board of directors. These additions have increased board membership to six. Steven Gillis, Ph.D., a managing director with ARCH, and Mary Campbell, a managing director at EDF Ventures, will serve as board observers.

Lycera also announced that it has expanded its development initiatives for small-molecule immunomodulators through the addition of a program targeting the Th17 pathway discovered by Dan Littman, M.D., Ph.D. Dr. Littman, the Helen L. and Martin S. Kimmel professor of molecular immunology and professor of pathology and microbiology at the Skirball Institute of Biomolecular Medicine of New York University School of Medicine, an investigator of the Howard Hughes Medical Institute, and a member of the National Academy of Sciences, will serve as chairman of the company's scientific advisory board.

"This financing round is an important validation of the Lycera technology platforms," said Dr. Gary Glick, Lycera's founder and chief scientific officer. "The company is fortunate to be working with a distinguished, talented and experienced group of investors. Their expertise in the dis
'/>"/>

SOURCE Lycera Corp.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. ViewRay Incorporated Closes $15M Tranche of Series B Financing and Announces Partnership with Siemens AG
2. Beckman Coulter Announces First Quarter 2009 Earnings to be Released on Tuesday, April 28, 2009, After Market Closes
3. Cell Biosciences Closes $10 Million Series C Financing
4. Index Ventures Closes Euro 350 Million Early Stage Fund
5. Mach One Closes on Acquisition of Biopharmaceutical Design & Engineering Firm
6. Opsona Therapeutics Closes EUR18M Funding
7. iCo Therapeutics Closes $1.3 Million Private Placement
8. Beckman Coulter Announces Fourth Quarter 2008 Earnings to be Released on Monday, February 9, 2009, After Market Closes
9. Lytix Closes USD 10.4 Million Funding Round
10. Singulex Closes $19 Million Financing Round
11. Karolinska Development Closes Fully Subscribed New Share Issue
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/28/2015)... , May 27, 2015 Research ... addition of Jain PharmaBiotech,s new report ... their offering. An increasing use ... industries is anticipated. Nanotechnology will be applied ... from formulations for optimal delivery to diagnostic ...
(Date:5/28/2015)... May 28, 2015 The Academy of Model ... Aviation Day on August 15, 2015. National Model Aviation Day ... and to introduce model flying to the general public. , ... clubs to participate in the celebration by hosting events in ... host National Model Aviation Day events. View our online ...
(Date:5/28/2015)... TX (PRWEB) May 28, 2015 ... association serving and representing the life sciences industry ... Board of Directors meeting at The Foundry in ... of the organization brought together a broad spectrum ... and underscored the organization's early successes in partnering ...
(Date:5/28/2015)... GAITHERSBURG, Md. , May 28, 2015  GenVec, ... president and CEO, Douglas J. Swirsky , will ... Healthcare Conference at 11 a.m. EDT on Thursday, June ... webcast of Mr. Swirsky,s presentation will be available at ... also be available on GenVec,s website.  To access, visit ...
Breaking Biology Technology:Global Nanobiotechnology Market 2015-2024 - Applications, Markets and Companies 2Global Nanobiotechnology Market 2015-2024 - Applications, Markets and Companies 3Model flying pilots celebrate the Academy of Model Aeronautics Foundation’s Third Annual National Model Aviation Day 2BioNorthTX Holds Inaugural Board of Directors Meeting 2BioNorthTX Holds Inaugural Board of Directors Meeting 3GenVec To Present At The Jefferies Healthcare Conference 2
... YORK , Feb. 10 Intellect ... company focused on development of disease-modifying therapeutic agents for ... significant shareholders (the "Interested Shareholders") have agreed in principle ... the Company in its efforts to restructure its balance ...
... YORK , Feb. 10 DuPont (NYSE: ... he expects the DuPont Agriculture & Nutrition segment to grow sales ... across the seed, crop protection, and nutrition and health businesses.   ... is paying off," Borel said at the Goldman Sachs 14th Annual ...
... Additional AeroLEF patents granted in Europe , China ... Feb. 10 /PRNewswire-FirstCall/ - YM BioSciences Inc. (NYSE ... additional patents in the US for AeroLEF(R), the Company,s proprietary, ... the treatment of moderate to severe acute pain. US patent ...
Cached Biology Technology:Intellect Neurosciences, Inc. Announces Preliminary Agreement with Significant Shareholders to Provide Interim Funding and Assist the Company in Efforts to Secure Additional Financing 2Intellect Neurosciences, Inc. Announces Preliminary Agreement with Significant Shareholders to Provide Interim Funding and Assist the Company in Efforts to Secure Additional Financing 3Intellect Neurosciences, Inc. Announces Preliminary Agreement with Significant Shareholders to Provide Interim Funding and Assist the Company in Efforts to Secure Additional Financing 4DuPont Expects Strong 2010 Agriculture & Nutrition Sales Growth, Margin Expansion 2DuPont Expects Strong 2010 Agriculture & Nutrition Sales Growth, Margin Expansion 3DuPont Expects Strong 2010 Agriculture & Nutrition Sales Growth, Margin Expansion 4DuPont Expects Strong 2010 Agriculture & Nutrition Sales Growth, Margin Expansion 5YM BioSciences granted two US patents for AeroLEF(R) 2YM BioSciences granted two US patents for AeroLEF(R) 3YM BioSciences granted two US patents for AeroLEF(R) 4
(Date:5/5/2015)... May 5, 2015, NXT-ID, Inc. (NASDAQ: NXTD ... on the growing mobile commerce market, reminds investors and media ... Officer, is presenting  at CARTES SECURE CONNEXIONS AMERICA 2015, held ... The three-day conference is organized into a ... in is themed Global Fraud: Where is the Trust ...
(Date:4/27/2015)... LAUDERDALE, Fla. , Apr. 27, 2015 ... of access control and security systems is pleased to ... the company as a consultant and member of its ... is widely known as a thought leader in ... Distance Learning Technology Group, and has published studies and ...
(Date:4/20/2015)... 20, 2015 The announcement comes ... Glenbeigh Records Management (GRM), Ireland,s foremost ... Bank. Having built up an impressive track record of clients ... player within the records management sector in Dubai ... is GCC staffbase and employ a further eight staff members ...
Breaking Biology News(10 mins):NXT-ID, Inc.'s CTO, David Tunnell, Presents at CARTES SECURE CONNEXIONS AMERICA 2015 Today in Washington DC. 2NXT-ID, Inc.'s CTO, David Tunnell, Presents at CARTES SECURE CONNEXIONS AMERICA 2015 Today in Washington DC. 3Profile Solutions Names Medicinal Cannabis, Agriculture and Technology Expert Dr. Gerry Bedore to its Scientific Advisory Board 2Profile Solutions Names Medicinal Cannabis, Agriculture and Technology Expert Dr. Gerry Bedore to its Scientific Advisory Board 3Profile Solutions Names Medicinal Cannabis, Agriculture and Technology Expert Dr. Gerry Bedore to its Scientific Advisory Board 4Glenbeigh Records Management Wins Contract With Dubai Islamic Bank 2Glenbeigh Records Management Wins Contract With Dubai Islamic Bank 3
... Cell DNA is a news aggregator that compiles life ... them online, and in a daily email digest format, free ... digests, readers can comment on, or tweet their favorite news ... subscribe to receive daily news direct to their email in-box ...
... Powdery mildew is a fungus that infects both crop ... pathogens cause immense crop loss. Despite decades of intense research, ... hyphae to invade the host,s epidermal cells. A European research ... University of Zurich, now published a study in Science ...
... November 2010 The Aeras Global TB Vaccine Foundation ... Foreign Affairs has renewed its funding to Aeras with ... years (2011-2014) to further its efforts to develop new ... This expression of support represents a ...
Cached Biology News:Fertility or powdery mildew resistance? 2Fertility or powdery mildew resistance? 3Aeras awarded €11.7 million ($16 million) grant from Dutch government 2
... PGF2α) is a metabolite of the ... monkeys and humans. 8-iso PGF2α is ... peroxidation. In both humans and monkeys, ... to metabolites having 2 or 4 ...
kismet (dK-20)...
...
Porcine Pulmonary Artery Endothelial Cells (PPAEC) (>500,000 cells)...
Biology Products: